A MORE COST EFFECTIVE HEALTH CARE THROUGH GOOD MANUFACTURING PRACTICE
From what has been heard during the first day of the conference devoted to the review of national situations by representatives of National Regulatory Authorities of the Member States, the situation is still far from satisfactory. With the exception of the market segment represented by in-vitro diagnostic products, technical trade barriers are still one of the major obstacles to market transparency. Working groups on electromedical devices and on sterile medical products, which met on the second day of the conference, recommended that ad-hoc parties be set up with the participation of representatives from the Commission, national regulatory authorities of the Member States of the Community and of the EFTA countries, European Manufacturers Associations, etc. to explore the feasibility of a common GMP or, more practically, define terms and evaluate opportunities for implementing existing GMPs and their mutual recognition.
Bibliographic Reference: JOURNAL OF MEDICAL ENGINEERING & TECHNOLOGY, VOL. 10 (1986), NO. 1, PP. 51-209, (EUR 9604).
Availability: Can be ordered online
Record Number: 1989124068500 / Last updated on: 1987-01-01
Available languages: en